-
As expected, the U.S. Food and Drug Administration (FDA) has given loratadine (Claritin) over-the-counter (OTC) status. Loratadine, the only nonsedating antihistamine available OTC, is approved for seasonal allergic rhinitis.
-
The cost of prescription drug coverage is expected to continue to increase at a rate of nearly 20% in 2003, according to a report released in late November.
-
-
Fondaparinux sodium (Arixtra) is the first of a new class of synthetic antithrombotic agents, known as the selective Factor-Xa inhibitors.
-
An investigational vaccine has reduced the incidence of both human papillomavirus type 16 (HPV-16) infection and HPV-16-related cervical intraepithelial neoplasia (pre-cancer of the cervix), according to research published in the Nov. 21, 2002, issue of the New England Journal of Medicine.
-
With a new year unfolding, Drug Utilization Review (DUR) takes this opportunity to look ahead at pharmacy practice, regulation, and the continued battle for pharmacists to receive provider status.
-
Whether they want to lose a few pounds that were added over the holidays or develop a more comprehensive weight-loss goal, many of your patients will resolve to lose weight in the new year.
-
La Puma J. Coenzyme Q10 and Parkinson's disease. Altern Med Alert 2003;6(1):12.
-
O'Mathuna DP. Anabolic-androgenic steroids for athletes: Adverse effects. Altern Med Alert 2003;6(1):8-11.
-
Ramalanjaona G. Ginkgo biloba for memory enhancement: An update. Altern Med Alert 2003;6(1):1-5.